当前位置: X-MOL 学术Planta Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Screening of Bufadienolides from Toad Venom Identifies Gammabufotalin as a Potential Anti-inflammatory Agent
Planta Medica ( IF 2.1 ) Pub Date : 2020-10-13 , DOI: 10.1055/a-1248-2626
Yuanru Zheng 1, 2 , Lijuan Deng 3 , Huihui Cao 1, 2 , Nishan Xu 1, 2 , Dongmei Zhang 4 , Haiyan Tian 4 , Baojing Li 5 , Zibin Lu 1, 2 , Wencai Ye 4 , Linzhong Yu 1, 2 , Chunlin Fan 4 , Junshan Liu 1, 2
Affiliation  

Toad venom (Chansu) is used in the treatment of infectious and inflammatory diseases in China and East/Southeast Asian countries. However, the anti-inflammatory components of toad venom have not yet been systematically evaluated and clearly defined. To investigate the anti-inflammatory effects of toad venom and identify new anti-inflammatory ingredients, we used zebrafish, an alternative drug screening model, to evaluate the anti-inflammatory effects of 14 bufadienolides previously isolated from toad venom. Most of the bufadienolides were found to exert significant anti-inflammatory effects on lipopolysaccharide-, CuSO4-, or tail transection-induced zebrafish inflammatory models. Moreover, gammabufotalin ( 6: ) inhibits lipopolysaccharide-induced inflammation by suppressing the myeloid differentiation primary response 88/nuclear factor-kappa B and STAT3 signal pathways. This study confirms the potential of zebrafish in drug screening, clarifies the anti-inflammatory effects of bufadienolides from toad venom, and indicates that gammabufotalin may be developed as a novel therapeutic agent for inflammatory diseases in the future.
更新日期:2020-10-13
down
wechat
bug